Hypesthesia: Clinical Trials

2 recruiting. 2 Phase 2, 2 Phase 3.

By phase and status

Phase	Trials	Status
Phase 2	2	Recruiting 2
Phase 3	2	Recruiting 2

Follow Hypesthesia: new trials by email Literature Review of Hypesthesia trials Research Report on Hypesthesia

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Ozone Treatment in Paresthesia (Numbness, Tingling) Secondary to Chemotherapy-induced Peripheral Neuropathy Ozone therapy, Oxygen (placebo) - Chemotherapy Induced Peripheral Neuropathy (CIPN), Paresthesia	Phase 2 / Phase 3	Recruiting	Bernardino Clavo, MD, PhD	42	2025-02-07	2026-09-18
Gut Microbiome Profiles in Patients With Chemotherapy-induced Neuropathy in the RCT OzoParQT (NCT06706544). Ozone therapy, Oxygen (placebo) - Chemotherapy Induced Peripheral Neuropathy (CIPN), Paresthesia	Phase 2 / Phase 3	Recruiting	Bernardino Clavo, MD, PhD	42	2025-02-07	2026-09-25

Narrower conditions

Anxiety Disorders (2)  ·  Depression (2)  ·  Paresthesia (2)

Broader conditions

Behavior (2)  ·  Behavioral Symptoms (2)  ·  Mental Disorders (2)  ·  Nervous System Diseases (2)  ·  Neurologic Manifestations (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Sensation Disorders (2)  ·  Signs and Symptoms (2)  ·  Somatosensory Disorders (2)

Interventions

Oxygen (2)

Sponsors

Bernardino Clavo, MD, PhD (2)

Countries

Spain (2)

Top investigators

Bernardino Clavo, MD, PhD (2)  ·  Himar Fabelo, BSc, PhD (1)  ·  Jacob Lorenzo-Morales, Prof (1)

Results publications

PMID 41572235